Customs duty on import of Remdesivir injection, Remdesivir API and Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir, up to 31st October, 2021

Last updated: 21 April 2021

Save Share

Quick Summary

The Indian government has extended the customs duty exemption for Remdesivir injections, the active pharmaceutical ingredient (API) for Remdesivir, and Beta Cyclodextrin (SBEBCD) used in its manufacture. This exemption applies to imports into India and is valid until 31st October 2021. The exemption is granted under specific conditions, including adherence to the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017 for SBEBCD.

GOVERNMENT OF INDIA

MINISTRY OF FINANCE

(DEPARTMENT OF REVENUE)

Notification No. 27/2021-Customs

New Delhi, the 20^th April, 2021

G.S.R. (E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do, hereby exempts the goods of the description specified in column (3) of the Table below, falling within the Chapter, heading, sub–heading or tariff item of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975) specified in column (2) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon under the said First Schedule, namely‑

Table

S. No.	Chapter or heading or sub–heading or tariff item	Description of goods
(1)	(2)	(3)
1.	29	Remdesivir Active Pharmaceutical Ingredients.
2.	29	Beta Cyclodextrin (SBEBCD) used in manufacture of Remdesivir, subject to the condition that the importer follows the procedure set out in the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017.
3.	30	Injection Remdesivir.

2. This notification shall remain in force upto and inclusive of the 31^st October, 2021.

[F.No. 354/3/2021-TRU]

(Gaurav Singh)

Deputy Secretary to the Government of India

FAQ :

The exemption covers Remdesivir injections, Remdesivir Active Pharmaceutical Ingredients (API), and Beta Cyclodextrin (SBEBCD) when used in the manufacture of Remdesivir.

This notification remains in force up to and including 31st October 2021.

The exemption is issued by the Central Government of India, Ministry of Finance (Department of Revenue).

Yes, for Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir, the importer must follow the procedure set out in the Customs (Import of Goods at Concessional Rate of Duty) Rules, 2017.

Notification No : 27/2021-Customs
Source : https://www.cbic.gov.in/resources//htdocs-cbec/customs/cs-act/notifications/notfns-2021/cs-tarr2021/cs27-2021.pdf

147 Views Comment Share Custom Report

Notification posted by

CCI News Desk

Finance news reporter covering taxation, GST, income tax, business compliance, and economy updates. I simplify complex financial topics into easy-to-understand articles for professionals, taxpayers, and business owners on leading finance and tax platforms.

Comments